CellFE
cellfebiotech.com
Actively hiring
Regenerative Medicine
Cell & Gene Therapy
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
2
Cota Capital, M Ventures
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Cota Capital 
M Ventures Similar startupsby what they do, their industry and backers
Astraveus is a biotech startup based in Paris, France. We strive to enable a healthier tomorrow. We believe in the therapeutic potential of…
We bring cell therapies to patients through innovative point-of-care manufacturing solutions.
About Us Cell Therapies for Life-Threatening Diseases LyGenesis, Inc. is a clinical-stage cell therapy company that transforms a patient's…
Designer cell therapies for pets first and their people next.
Arsenal Biosciences, Inc. is a clinical stage, programmable cell therapy company focused on solid tumor cell therapies to defeat cancer.
Acorn is a personalized regenerative medicine company, helping people preserve their own cells to prepare for the future of cell-based…
News
CellFE and Made Scientific Announce Strategic Collaboration to Advance Non-viral Gene Editing for T Cell Therapies
CellFE and Made Scientific announce a strategic collaboration to generate pilot data on the CellFE High Volume Cyva System. The post CellFE and Made Scientific Announce Strategic Collaboration to Advance Non-viral Gene Editing for T Cell Therapies appeare
Read more
Report
CellFE and Made Scientific Announce Strategic Collaboration to Advance Non-viral Gene Editing for T Cell Therapies
CellFE, a leader in microfluidics-based cell engineering, and Made Scientific, a leading cell therapy contract development and manufacturing organization (CDMO), today announced a strategic collaboration to generate pilot data on the CellFE High Volume Cy
Read more
Report
CellFE Partners with DKFZ and TcellTech to Advance DNA Vector Genetic Engineering for Cellular Therapies
CellFE, a leader in non-viral gene editing technology, announces a strategic collaboration with the Harbottle Lab at German Cancer Research Center (DKFZ) and its spin-out company, TcellTech. The post CellFE Partners with DKFZ and TcellTech to Advance DNA
Read more
Report
Application Note: Efficient Gene Editing of iPSCs
CellFE releases a cGMP-compatible workflow to support highly efficient gene editing of iPSCs via a non-viral approach for cell therapy manufacturing. The post Application Note: Efficient Gene Editing of iPSCs appeared first on CellFE.
Read more
Report
CellFE Announces Launch of First-in-Class T-Rest ("Resting T Cell Kit") for Breakthrough CAR-T Cell Therapy Manufacturing
CellFE, a leader in non-viral gene editing technology, today announced the launch of its highly anticipated CellFE T-Rest ("Resting T Cell Kit"), a first-in-class cell manufacturing transfection media product designed specifically for resting (quiescent)
Read more
Report
Pro access
Upgrade to see all 18 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Hayward
United States
Regional office
CellFE
25801 Industrial Blvd Ste 100, Hayward, CA 94545, USA